Given that TGFB has been identified as an important factor for controlling CD8+ T cell mediated inflammation (28–32), we provide new makers in CD8+ T cells that are associated with the BPD and PRD. The gene discussed is CD8A; the disease is bronchopulmonary dysplasia.